These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7873818)

  • 1. Normal-range plasma catecholamines in patients with generalized and acrofacial vitiligo: preliminary report.
    Orecchia G; Frattini P; Cucchi ML; Santagostino G
    Dermatology; 1994; 189(4):350-3. PubMed ID: 7873818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher plasma catecholamine and metabolite levels in the early phase of nonsegmental vitiligo.
    Cucchi ML; Frattini P; Santagostino G; Orecchia G
    Pigment Cell Res; 2000 Feb; 13(1):28-32. PubMed ID: 10761993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between plasma and cerebrospinal fluid norepinephrine and dopamine metabolites in a nonhuman primate.
    Greene KA; Faull KF
    J Neurochem; 1989 Oct; 53(4):1007-13. PubMed ID: 2769251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of handling or immobilization on plasma levels of 3,4-dihydroxyphenylalanine, catecholamines, and metabolites in rats.
    Kvetnanský R; Goldstein DS; Weise VK; Holmes C; Szemeredi K; Bagdy G; Kopin IJ
    J Neurochem; 1992 Jun; 58(6):2296-302. PubMed ID: 1573408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma monoaminergic metabolites and catecholamines in subarachnoid hemorrhage. Clinical implications.
    Minegishi A; Ishizaki T; Yoshida Y; Ahagon A; Shibata N; Kobayashi H
    Arch Neurol; 1987 Apr; 44(4):423-8. PubMed ID: 2435272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sources and significance of plasma levels of catechols and their metabolites in humans.
    Goldstein DS; Eisenhofer G; Kopin IJ
    J Pharmacol Exp Ther; 2003 Jun; 305(3):800-11. PubMed ID: 12649306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catecholamines increase in the urine of non-segmental vitiligo especially during its active phase.
    Cucchi ML; Frattini P; Santagostino G; Preda S; Orecchia G
    Pigment Cell Res; 2003 Apr; 16(2):111-6. PubMed ID: 12622787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproducibility of plasma catecholamine metabolites in normal subjects.
    Amin F; Hashmi A; Stroe AE; Adebogun O; Densmore D; Knott PJ
    Biol Psychiatry; 1998 Feb; 43(3):233-5. PubMed ID: 9494706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catecholamines and vitiligo.
    Morrone A; Picardo M; de Luca C; Terminali O; Passi S; Ippolito F
    Pigment Cell Res; 1992 Mar; 5(2):65-9. PubMed ID: 1321419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of umbilical plasma concentrations of catecholamines and their metabolites in patients with term vaginal deliveries].
    Ishizuka B; Hirata K; Matsumoto K; Ohno Y; Watanabe K; Kondoh T; Horikoshi H; Shiozaki K; Hamada H
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jul; 43(7):729-34. PubMed ID: 1890351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine.
    Eisenhofer G; Brown S; Peitzsch M; Pelzel D; Lattke P; Glöckner S; Stell A; Prejbisz A; Fassnacht M; Beuschlein F; Januszewicz A; Siegert G; Reichmann H
    Ann Clin Biochem; 2014 Jan; 51(Pt 1):38-46. PubMed ID: 23873873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Catecholamines and their metabolites in children with Asperger and Kanner syndromes].
    Gorina AS; Kolesnichenko LS; Mikhnovich VI
    Biomed Khim; 2011; 57(5):562-70. PubMed ID: 22629607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of an improved liquid chromatography tandem mass spectrometry method for rapid and simultaneous analysis of plasma catecholamine and their metabolites.
    Yu S; Yin Y; Li Q; Yu J; Liu W; Wang D; Cheng Q; Xie S; Cheng X; Qiu L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Oct; 1129():121805. PubMed ID: 31670057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma catecholamines and their metabolites in obsessive-compulsive disorder.
    Benkelfat C; Mefford IN; Masters CF; Nordahl TE; King AC; Cohen RM; Murphy DL
    Psychiatry Res; 1991 Jun; 37(3):321-31. PubMed ID: 1891512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of diurnal fluctuations of plasma methoxyamines in healthy volunteers.
    Hoizey G; Lukas-Croisier C; Frances C; Grulet H; Delemer B; Millart H; Devillier P; Caron J
    Clin Endocrinol (Oxf); 2002 Jan; 56(1):119-22. PubMed ID: 11849255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of plasma and urinary monoamines and their metabolites in nonsegmental vitiligo.
    Shahin Z; Leheta TM; Abdel Hay RM; Abdel Aal HM; Rashed LA
    Acta Dermatovenerol Croat; 2012; 20(1):14-20. PubMed ID: 22507469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2.
    Eisenhofer G; Lenders JW; Linehan WM; Walther MM; Goldstein DS; Keiser HR
    N Engl J Med; 1999 Jun; 340(24):1872-9. PubMed ID: 10369850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous analysis of human plasma catecholamines by high-performance liquid chromatography with a reversed-phase triacontylsilyl silica column.
    Machida M; Sakaguchi A; Kamada S; Fujimoto T; Takechi S; Kakinoki S; Nomura A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(2):249-54. PubMed ID: 16301006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma & urinary catecholamines & urinary vanillylmandelic acid levels in patients with generalized vitiligo.
    Basnet B; Bhushan A; Khan R; Kumar G; Sharma VK; Sharma A; Gupta S
    Indian J Med Res; 2018 Apr; 147(4):384-390. PubMed ID: 29998874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catecholamine metabolites in internal jugular plasma: a window into the human brain.
    Lambert GW; Kaye DM; Thompson JM; Turner AG; Ferrier C; Cox HS; Vaz M; Wilkinson D; Meredith IT; Jennings GL; Esler MD
    Adv Pharmacol; 1998; 42():364-6. PubMed ID: 9327917
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.